| Overriding of drug safety alerts in computerized physician order entry H Van Der Sijs, J Aarts, A Vulto, M Berg Journal of the American Medical Informatics Association 13 (2), 138-147, 2006 | 1233 | 2006 |
| Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. CH Lamers, S Sleijfer, AG Vulto, WH Kruit, M Kliffen, R Debets, ... Journal of clinical oncology: official journal of the American Society of …, 2006 | 1107 | 2006 |
| Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity CHJ Lamers, S Sleijfer, S Van Steenbergen, P Van Elzakker, ... Molecular therapy 21 (4), 904-912, 2013 | 789 | 2013 |
| Long-term intravenous treatment of Pompe disease with recombinant human α-glucosidase from milk JMP Van den Hout, JHJ Kamphoven, LPF Winkel, WFM Arts, JBCD Klerk, ... Pediatrics 113 (5), e448-e457, 2004 | 416 | 2004 |
| Recombinant human α-glucosidase from rabbit milk in Pompe patients H Van den Hout, AJJ Reuser, AG Vulto, MCB Loonen, A Cromme-Dijkhuis, ... The Lancet 356 (9227), 397-398, 2000 | 414 | 2000 |
| glycyrrhizin as a potential treatment for chronic hepatitis C. TGJ Van Rossum, RA De Man Alimentary pharmacology & therapeutics 12 (3), 1998 | 375 | 1998 |
| Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial BJ Rijnders, JJ Cornelissen, L Slobbe, MJ Becker, JK Doorduijn, ... Clinical infectious diseases 46 (9), 1401-1408, 2008 | 331 | 2008 |
| Enzyme replacement therapy in late‐onset Pompe's disease: a three‐year follow‐up LPF Winkel, JMP Van den Hout, JHJ Kamphoven, JAM Disseldorp, ... Annals of neurology 55 (4), 495-502, 2004 | 277 | 2004 |
| Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function AH van den Meiracker, RGA Baggen, S Pauli, A Lindemans, AG Vulto, ... Journal of hypertension 24 (11), 2285-2292, 2006 | 243 | 2006 |
| Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double‐blind, randomized, placebo‐controlled phase I/II trial TGV Rossum, AG Vulto, WCJ Hop, JT Brouwer, HG Niesters, SW Schalm Journal of gastroenterology and hepatology 14 (11), 1093-1099, 1999 | 242 | 1999 |
| Policies for biosimilar uptake in Europe: an overview E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ... PloS one 12 (12), e0190147, 2017 | 233 | 2017 |
| Turning off frequently overridden drug alerts: limited opportunities for doing it safely H Van Der Sijs, J Aarts, T Van Gelder, M Berg, A Vulto Journal of the American Medical Informatics Association 15 (4), 439-448, 2008 | 202 | 2008 |
| A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital GW 't Jong, AG Vulto, M de Hoog, KJM Schimmel, D Tibboel, ... Pediatrics 108 (5), 1089-1093, 2001 | 200 | 2001 |
| Guidelines for the practical stability studies of anticancer drugs: a European consensus conference C Bardin, A Astier, A Vulto, G Sewell, J Vigneron, R Trittler, M Daouphars, ... Annales pharmaceutiques francaises 69 (4), 221-231, 2011 | 197 | 2011 |
| Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C TGJ Van Rossum, AG Vulto, WCJ Hop, SW Schalm Official journal of the American College of Gastroenterology| ACG 96 (8 …, 2001 | 194 | 2001 |
| Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β‐Blocker Users MJ Bijl, LE Visser, RHN Van Schaik, JA Kors, JCM Witteman, A Hofman, ... Clinical Pharmacology & Therapeutics 85 (1), 45-50, 2009 | 178 | 2009 |
| The process defines the product: what really matters in biosimilar design and production? AG Vulto, OA Jaquez Rheumatology 56 (suppl_4), iv14-iv29, 2017 | 167 | 2017 |
| The CYP2D6* 4 polymorphism affects breast cancer survival in tamoxifen users MJ Bijl, RHN van Schaik, LA Lammers, A Hofman, AG Vulto, T van Gelder, ... Breast cancer research and treatment 118, 125-130, 2009 | 154 | 2009 |
| Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty TM van Raaij, LE Visser, AG Vulto, JAN Verhaar The Journal of arthroplasty 17 (7), 948-950, 2002 | 150 | 2002 |
| Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel FK Engels, AJ Ten Tije, SD Baker, CKK Lee, WJ Loos, AG Vulto, J Verweij, ... Clinical Pharmacology & Therapeutics 75 (5), 448-454, 2004 | 143 | 2004 |
Ron van SchaikProfessor Pharmacogenetics, ErasmusVerified email at erasmusmc.nl
